Sera Prognostics Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results All four companies posted net losses for the quarter, while Biodesix's results were hit by a sharp decline in COVID-19 testing revenue. People in the News: New Appointments at Thermo Fisher, Sera Prognostics, PreludeDx, More Industry Pros Suggest Proteomic Dx Technology Ready for Routine Application Premium They acknowledge that while the technical hurdles of proteomic test development have become manageable, commercialization is still a major challenge. Fresh Off LabCorp Launch, Sera Publishes Analytical Validation for PreTRM Test Premium The study details the validation of the mass spec-based preterm birth test, which the company launched nationwide last month through its agreement with LabCorp. Sera Prognostics' Deal with LabCorp Brings Potential Risks, Rewards Premium The agreement will allow Sera to leverage LabCorp's sales force and networks, but similar deals have failed to deliver for proteomics firms in the past. Jan 10, 2017 LabCorp to Distribute Sera's PreTRM Test, Lead $40M Series C Round Dec 23, 2016 Model Suggests Sera's PreTRM Test Could Offer Big Cost Savings, Though More Data Needed Premium Mar 11, 2016 With Validation Data Published, Reimbursement the Next Hurdle for Sera's PreTRM Test Premium Mar 10, 2016 Sera Publishes Validation Study of PreTRM Proteomic Test for Risk of Preterm Delivery Feb 4, 2016 Sera Prognostics Presents Results From Validation Study of PreTRM Test Premium Oct 23, 2015 Another Mass Spec Test Moves to Clinic as Sera Launches Preterm Birth Risk Panel Premium Feb 4, 2015 Sera Increases Series B Round to $25M with $5M from Gates Foundation Jan 9, 2015 Sera Planning 2015 Launch of PreTRM Proteomic Test to Assess Preterm Delivery Risk Premium Jan 7, 2015 Sera Prognostics Closes $20M Series B Financing Round Sep 6, 2013 People in the News: Lee Hood to Serve as Scientific Advisor to Sera Prognostics Premium Aug 23, 2013 Sera Completes Enrollment of 5,500 Patients for PreTRM Validation, Pushes Back Test Launch to 2014 Premium Mar 29, 2013 Changing Course, Applied Proteomics to Offer Colon Test via Mass Spec Instead of Immunoassay Premium Mar 1, 2013 Sera Prognostics' 4,000-Patient Validation Study Another Sign of High-Throughput Mass Spec's Arrival Premium Feb 12, 2013 Agilent, Sera Prognostics Team on Proteomic Assays Feb 1, 2013 Stanford Spinout Carmenta Bioscience Prepping Validation Study of Preeclampsia Protein Dx Premium Jan 4, 2013 2012 Sees Rise of Targeted Proteomics and DIA-MS, Continued Clinical Push by Big Industry Players Premium Nov 7, 2012 People: Greg Critchfield Premium Oct 5, 2012 People in the News: Sera Prognostics, Biomarker Strategies Premium Sep 21, 2012 Targeted Mass Spec Slowly but Steadily Moving Toward Broader Commercial, Clinical Adoption Premium Jul 13, 2012 Pronota Validates Pre-Eclampsia Markers; Plans Clinical Study to Support 510(k) Submission Premium Load More Breaking News Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Gut Microbiome Characteristics Tied to Depressive Symptoms in New Studies Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients Cowen Upgrades PerkinElmer Stock to Outperform CareDx to Repurchase up to $50M of Common Stock The Scan Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan. Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus. Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities. Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.